APEIRON Biologics
Ulrich Granzer has a wide range of experience in all aspects of drug development and regulatory affairs, including drug safety and GXP.
This person is not in the org chart
This person is not in any offices
APEIRON Biologics
Apeiron, based in Vienna, Austria, is focused on the development of novel cancer Immunotherapies.